Combinations of LSD1 inhibitors for use in the treatment of solid tumors
US10265279B2 · kind B2 · utility
1Cited by
26References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2017 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Mar 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredient(s) or pharmaceutically acceptable salts thereof. The combinations are particularly useful for treating neoplastic diseases, such as cancer, particularly small cell lung cancer (SCLC).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.